Pharmed Group.....           McKesson may be defending distribution turf by eyeing Uniprix, say analysts.....           Big Pharma: What Safe Haven?.....           Optimer to secure $12.2 million in financing.....           Inion wins approval to market graft containment systems.....           Metabolon implements metabolomics platform at Pfizer.....           Pawfect Foods acquires Synergy Pharmaceuticals.....           Cenix signs research agreement with Regulus Therapeutics.....           Tekmira selects two products for clinical development in 2009.....           TeleHealth and Vocollect sign reseller agreement.....           Alnylam grants new InterfeRx license to Calando.....           American Laser Centers names new CIO.....           HealthTronics acquires UroPath.....           Allos initiates enrollment for Phase II bladder cancer trial.....           Curis selects new development candidate from cancer drug platform.....           Provectus initiates recruitment for Phase II cancer trial.....           Rexahn receives patent for new cancer compounds.....           Osmetech wins approval for warfarin sensitivity test.....           Santarus to promote Depomed's Glumetza prescription products.....           Tranzyme receives notices of allowance for two new patents.....           CardioNet announces public offering of common stock.....           Astellas and Boehringer file patent infringement lawsuit against Impax.....           US NIAID not to go ahead with HIV vaccine trial.....           Dr. Flemming Ornskov Nominated for Election as Chairman of the Supervisory Board of Evotec.....           Minority-owned company alleges health care firm used its status to obtain contracts.....           Akesis names new board member.....           MMRC initiates Phase I/II myeloma trial.....           Dor BioPharma and Steward Cross sign collaborative agreement.....           BMP Sunstone to acquire Shengda Pharmaceutical.....           OtisMed relocates headquarters.....           Qtrac Software signs partnership with Patient Placement Systems.....           Instead Healthcare and Health Sciences sign distribution agreement.....           Omnicell launches new wireless supply mobile cart.....           AcuNetx's president and CEO resigns.....           PharmEng granted site license from Health Canada.....           Allergan and Jan Marini to settle patent infringement suit.....           Agfa HealthCare wins new contract from Premier Purchasing Partners.....           Velcura names new board member.....           minSURG establishes new international division.....           ProtAffin wins orphan designation for anti-inflammatory drug.....           Sanofi-Aventis terminates commercialization agreement with Taiho.....           Sanofi-Aventis signs collaborative agreement with Johns Hopkins University.....           Invitrogen and Active Motif join hands in gene analysis.....           Roche to acquire all outstanding shares of Genentech.....           Advanced Bionics settles financial suit with FDA.....           Teva buys Barr Pharmaceuticals: The price tag reached $7.46 billion.........           Drug deals and soaps.....           Teva to buy Barr Pharma for more than $7 billion.....           ClinicAid and Quartesian Launch Joint CRO Venture Clinesian.....           Teva Enrolls Patients For A Second Large Global Phase III Trial Of Oral Laquinimod.....           Duramed parent Barr Pharmaceuticals to be acquired by Teva.....           Winner Medical granted patent approval for PurCotton production method.....           Thermo Fisher Scientific acquires Affinity BioReagents.....           OptiMedica names new CFO.....           Meditrina wins approval for Phase IIb endometriosis trial.....           Medtronic acquires Restore Medical.....           Intertrade Dental to distribute Zila's cancer screening products.....           Advanced Life Sciences and UK Ministry of Defence announce collaboration.....           MacroGenics acquires Raven Biotechnologies.....           Anesiva initiates Phase II study of pain drug.....           China Medicine granted new Australian patent.....           Isis names new vice president and CMO.....           Schering-Plough wins Japanese marketing approval for Nasonex.....           Dynova Laboratories acquires SiCap Industries.....           Misonix granted approval for Sonatherm tissue ablation system.....           Genzyme and PTC collaborate on genetic disorder drug.....           3M Health Care and Greystone sign licensing agreement.....           Calibrant signs R&D agreement with AFIP.....           Impliant introduces new version of Tops spine system.....           Cimex wins German approval for Clopidogrel.....           National Stem Cell to launch new cosmoceuticals line.....           Drug Stocks Mixed; Barr Soars On Takeover Talk.....           Pakistan government blocks proposal to import Indian drugs.....           More People Sign Up for Jobless Benefits in U.S......           Is Teva Looking to Buy Barr Pharmaceuticals?.....           Smiths Medical wins multi year contract from HealthTrust.....           Novartis extends RNAi therapeutics collaboration with Alnylam.....           Dendreon initiates Phase II prostate cancer trial.....           China Medical acquires distribution rights to macular degeneration drug.....           Theragenics to acquire NeedleTech Products.....           EpiCept and GNI join hands to develop hepatitis drug in Asia.....           Optimer reports positive results from Phase III diarrhea trial.....           Symphogen and Biovitrum recruit first patient for Phase II ITP study.....           Iris receives purchase order from Kuwait Ministry of Health.....           Generex obtains purchase order from distributor in Saudi Arabia.....           Immunosyn announces proposed agreements for distribution of autoimmune drug.....           Omnicare acquires Advanced Care Scripts.....           Galderma wins Japanese approval for Differin gel 0.1%.....           Bioenergy appoints new CEO.....           Alverix names new president and CEO.....           Misonix signs new distribution agreement with Intermedica.....           Huifeng signs strategic alliance with Premier Media Service.....           Bellus Health to acquire Innodia.....           Asubio's Biopten wins approval for additional indication.....           BG Medicine secures $40 million in series D financing.....           Import of Indian drugs blocked by Pak govt.....           Pharma cuts down its sales force.....           Roche Pharma suspended from body.....           Wyeth, Impax get court approval of Effexor patent suit settlement.....           Spineology raises $7.5 million in financing.....           Nutrition 21 names new president and CEO.....           Medtronic wins Japanese approval for Reveal DX cardiac monitor.....           Ingenuity Systems and CHDI sign multi-year deal.....           Rib-X initiates Phase II skin infection trial.....           Abeome and Cato Research to collaborate on ovarian cancer drug.....           MedX signs distribution agreement with Technology4Medicine.....           Remedi SeniorCare acquires HealthCare Pharmacy.....           InTouch Health signs collaboration agreement with Genentech.....           Metabolon expands multi-study agreement with Mitsubishi Tanabe.....           Wyeth to acquire ThermaCare from Procter & Gamble.....           Alfacell signs Onconase distribution agreement with Megapharm.....           Dor BioPharma signs collaboration agreement with IDIS.....           Draximage to market Neoprobe's Lymphoseek in Europe.....           Duke University Hospital acquires TraumaCad from Orthocrat.....           Medicago to conduct feasibility study for vaccine facility in France.....           Dyax enters negotiation period with Dompe for angioedema drug.....           ViroPharma to acquire Lev Pharmaceuticals.....           EyeGate initiates dosing in Phase II uveitis trial.....           Mylan Inc. sued over painkilling patch deaths.....           Roxane wins approval for Morphine sulfate tablets and oral solution.....           RxElite signs supply and marketing agreement with Hi-Tech Pharmacal.....           ThermoGenesis granted approval to market MarrowXpress.....           DiaMedica's Phase II diabetes trial meets end point.....           SurModics's subsidiary licenses nanoparticle technology from PharmaSol.....           Noven names new vice president and CMO.....           Amgen reports positive results for treatment of bone loss in cancer study.....           SyntheMed wins Canadian approval for Repel-CV.....           Theravance reports encouraging results from Phase I COPD trial.....           Spherix to expand Phase III diabetes trial.....           IHSI acquires two operating subsidiaries from HealthSonix.....           Synta appoints new senior vice president and CCO.....           Gene Logic renews agreement with Agilent Technologies.....           MitoSciences signs new agreement with Hospital for Sick Children, Canada.....           Cardiome reports positive results from Phase II atrial fibrillation study.....           Luminex signs licensing agreement with ViroNovative.....           Allergan acquires Aczone gel from QLT.....           WellPoint expands partnership with CareNex Health Services.....           Hemispherx settles Bioclones and Ribotech litigation.....           Penwest initiates dosing in Phase Ia mitochondrial disease trial.....            
"Photostability 2008"

The Photostability of Drugs Interest Group &
The Academy of Pharmaceutical Sciences
1st - 3rd October 2008
The Royal Pharmaceutical Society, London
This prestigious and focussed international meeting is aimed at pharmaceutical and analytical scientists who are involved in the design and execution of photostability and phototoxicity studies; project managers who need to know about the impact of photostability issues on drug development and pharmaceutical industry users who need to identify critical issues in the management of photostability studies.

The optional one-day photostability course (1st October) provides a comprehensive background on the scientific, regulatory and practical issues in pharmaceutical photostability testing. Speakers will be experts in their fields drawn from Academia and the pharmaceutical Industry [Click here for further details].

The succeeding two day scientific conference will allow participants to consider all aspects of the photostability of drug substances and their formulations, including photochemistry and photophysics; light protection of drugs and formulation of photosensitive drugs; choice and calibration of irradiation sources; experimental set up and testing protocols; analytical techniques for screening of photoreactivity; photobiological testing and related phototoxicity; photodynamic therapy [Click here for further details].

There will be ample opportunity to informally mix with, and learn from, experts in these fields including at the planned social events.

On each day there will be a “brains trust” session where a panel of experts will answer questions from delegates on a particular issue they may be having in this important area. There will also be a vendor exhibition to aid delegates in accessing goods and services in this field.

We also invite submission of papers or posters in any of these areas for consideration by the international steering committee.  Abstracts should be submitted via the web site (www.photostability.org) as soon as possible and in any case by the end of June 2008.

Registered in England. No 4245751. Registered Office: 840 Melton Road, Thurmaston, Leicester, LE4 8BN